The Financial Supervisory Commission (FSC) said yesterday it is mulling measures to crack down on “back-door listing” irregularities as a stock manipulation scandal surrounding Genome International Biomedical Co (基因國際) grows.
“Securities officials are reviewing back-door listing practices and may draw up an exit mechanism for companies with financial troubles or facing difficulty in trading shares,” commission Chairman William Tseng (曾銘宗) told lawmakers on the legislature’s Finance Committee.
Tseng was fielding questions over the probe into Genome, a Taipei-based medical equipment and healthcare services company, as well as the Top Pot Bakery chain (胖達人), which made headlines in August after it was found to be using artificial flavorings in what it claimed were “all-natural” products.
Genome was granted permission to trade its shares on the nation’s over-the-counter GRETAI Securities Market in December 2011 by acquiring an unprofitable chipmaker.
A back-door listing occurs when a privately held company not qualified for the public offering process purchases a publicly traded company and therefore gains automatic inclusion on a stock exchange. Such a listing usually indicates significant weakness in the acquired company and serves as a warning sign for investors to be wary.
The commission’s Securities and Futures Bureau (SFB) will meet later this month to address the issue, Tseng said.
Shares in Genome plunged by its daily limit for the second consecutive day yesterday to close at NT$74.3, bucking the TAIEX’s 1.73 percent gain, Taiwan Stock Exchange data showed, as sellers sought to dump shares, but could not find buyers.
Genome stock shed 42 percent for the past three months, while biotechnology players rallied 13.18 percent and the OTC index picked up 5.52 percent, according to the local bourse.
The company said in a stock filing it would cooperate with the investigation, which has no impact on its operations or financial standing.
Tseng said the delisting mechanism, once put into practice, would not have a back-dated effect on currently listed firms.
Securities officials would draw up a list of back-door listing companies and step up inspections as they tend to have financial or management problems.
Currently, firms may volunteer to delist, or be forced to do so at the request of regulators.
Share prices should not serve as an important reference, but not the decisive factor, in judging whether to delist a company or not, Tseng said, asking investors to be extra cautious about shares with abnormal movements.
The Securities and Futures Bureau’s new director-general, Wu Yui-chun (吳裕群), said shares with poor circulation are prone to manipulations.
Stock manipulation allegations have dogged Genome as its share prices soared from NT$60 in August last year to NT$212 in six months’ time, following its high-profile investment in Top Pot Bakery.
It shares nosedived this fall to NT$60 after the outbreak of the artificial flavorings scandal two months ago. The bakery chain refunded NT$85.75 million (US$2.9 million) to angry customers.
Genome is estimated to book NT$27 million in losses, in line with its stakes in the bakery, thereby weakening its earnings per share by NT$1 this year, local media reports said.
HORMUZ ISSUE: The US president said he expected crude prices to drop at the end of the war, which he called a ‘minor excursion’ that could continue ‘for a little while’ The United Arab Emirates (UAE) and Kuwait started reducing oil production, as the near-closure of the crucial Strait of Hormuz ripples through energy markets and affects global supply. Abu Dhabi National Oil Co (ADNOC) is “managing offshore production levels to address storage requirements,” the company said in a statement, without giving details. Kuwait Petroleum Corp said it was lowering production at its oil fields and refineries after “Iranian threats against safe passage of ships through the Strait of Hormuz.” The war in the Middle East has all but closed Hormuz, the narrow waterway linking the Persian Gulf to the open seas,
Nanya Technology Corp (南亞科技) yesterday said the DRAM supply crunch could extend through 2028, as the artificial intelligence (AI) boom has led the world’s major memory makers to dramatically reduce production of standard DRAM and allocate a significant portion of their capacity for high-bandwidth memory (HBM) chips. The most severe supply constraints would stretch to the first half of next year due to “very limited” increases in new DRAM capacity worldwide, Nanya Technology president Lee Pei-ing (李培瑛) told a news briefing. The company plans to increase monthly 12-inch wafer capacity to 20,000 in the first half of 2028 after a
Taiwan has enough crude oil reserves for more than 100 days and sufficient natural gas reserves for more than 11 days, both above the regulatory safety requirement, Minister of Economic Affairs Kung Ming-hsin (龔明鑫) said yesterday, adding that the government would prioritize domestic price stability as conflicts in the Middle East continue. Overall, energy supply for this month is secure, and the government is continuing efforts to ensure sufficient supply for next month, Kung told reporters after meeting with representatives from business groups at the ministry in Taipei. The ministry has been holding daily cross-ministry meetings at the Executive Yuan to ensure
RATIONING: The proposal would give the Trump administration ample leverage to negotiate investments in the US as it decides how many chips to give each country US officials are debating a new regulatory framework for exporting artificial intelligence (AI) chips and are considering requiring foreign nations to invest in US AI data centers or security guarantees as a condition for granting exports of 200,000 chips or more, according to a document seen by Reuters. The rules are not yet final and could change. They would be the first attempt to regulate the flow of AI chips to US allies and partners since US President Donald Trump’s administration said it rescinded its predecessor’s so-called AI diffusion rules. Those rules sought to keep a significant amount of AI